Christoph Huber

Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.

C. Huber, G. Sutter, M. Theobald, 1999, Cancer research.

Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man

M. Schuler, C. Huber, M. Theobald, 2002, Gene Therapy.

A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.

R. Herrmann, C. Bolliger, C. Rochlitz, 1998, Human gene therapy.